Overview
Roche Polska focuses on discovering new medicines, diagnostics and digital healthcare solutions. The company develops medicines, therapies and diagnostic solutions, conducts clinical research and has used energy exclusively from renewable sources in its buildings since 2024.
Financials
The financial statement for 2025 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
News
Press conference on hemophilia A on 31.08.2026
Information on the reimbursement status of Hemlibra (emicizumab)
Information on the reimbursement status of Hemlibra (emicizumab)
Information on the reimbursement status of Hemlibra (emicizumab)
Important information on the termination of distribution of Gavreto (pralsetinib) by Roche Polska
Information on the reimbursement status of Hemlibra (emicizumab) - update April 2, 2026
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
17 1880 0009 0000 0011 0283 5000
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Apr 30, 2014 | Return of additional payments |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
1347 tenders recorded as contractor: 180 national ($12,340,797) and 1167 EU ($8,427,506,646).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 15, 2026 | Zakup i dostawa leków przeciwnowotworowych, doustnych i dożylnych, refundowanych w ramach programów lekowych oraz z katalogu chemioterapii. | –– | Wielkopolskie Centrum Onkologii Im. Marii Skłodowskiej-Curie | |
| Oct 13, 2026 | Dostawa produktów farmaceutycznych w 51 pakietach. | –– | Samodzielny Publiczny Zespół Opieki Zdrowotnej w Kolbuszowej | |
| Oct 12, 2026 | Dostawa leków do chemioterapii i programów lekowych 2026-2028 | –– | Wojewódzki Szpital Specjalistyczny We Wrocławiu |
Public sector contracts
Roche Polska is the contractor in 190 public sector contracts, worth PLN 287.60m in total. They were signed with 79 public buyers. The largest number (3) were signed with Uniwersyteckie Centrum Kliniczne.
| Public buyer | Value | |
|---|---|---|
| Szpital Wojewódzki Im. Kardynała Stefana Wyszyńskiego w Łomży | PLN 11,437 | |
| Uniwersytecki Szpital Kliniczny Im. Jana Mikulicza-Radeckiego we Wrocławiu | PLN 74,074 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Imienia Doktora Kazimierza Hołogi | PLN 3,262 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej w Przeworsku | PLN 4,380 | |
| Uniwersytecki Dziecięcy Szpital Kliniczny Im. L. Zamenhofa w Białymstoku | PLN 3,272 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board jointly, or one member of the management board together with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Roche Finanz Ag | 25,000 | $6,753,106.43 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| NeucaS.A. | $3,440,344,801.61 | inwestor.neuca.pl | ||
| Polska Grupa FarmaceutycznaS.A. | $1,778,266,449.02 | pgf.com.pl | ||
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| MSD Polska Dystrybucjasp. z o.o. | $341,786,056.16 | msd.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Phoenix Pharma Polskasp. z o.o. | $140,768,509.34 | phoenixpharma.pl | ||
| Olympus Polskasp. z o.o. | $104,605,078.34 | olympus.pl | ||
| Magnapharm Polandsp. z o.o. | $90,512,785.67 | magnapharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-01-16 | Address change (Domaniewska 39b, 02-672, Warszawa → Ul. Domaniewska 28, 02-672, Warszawa) | |
| 2009-02-16 | Share capital change (2,000,000.00 PLN → 25,000,000.00 PLN) | |
| 2006-03-07 | Address change (Al. Jerozolimskie 146b, 02-305, Warszawa → Domaniewska 39b, 02-672, Warszawa) | |
| 2002-06-14 | Entered in the register |
FAQ
Last updated: 2026-10-07